α1β1 integrin is crucial for accumulation of epidermal T cells and the development of psoriasis

Nature Medicine

Volumn 13, Issue 7, 2007, Pages 836-842

  Conrad, Curdin ^a   Boyman, Onur ^a,d   Tonel, Giulia ^a,b   Tun Kyi, Adrian ^a   Laggner, Ute ^b   De Fougerolles, Antonin ^c   Kotelianski, Victor ^c   Gardner, Humphrey ^c   Nestle, Frank O ^b  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b GUY S HOSPITAL   (United Kingdom)

^c BIOGEN   (United States)

^d LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; GAMMA INTERFERON; INFLIXIMAB; LYMPHOCYTE SURFACE MARKER; MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; VERY LATE ACTIVATION ANTIGEN 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INTERACTION; CELL MIGRATION; CONTROLLED STUDY; DISEASE COURSE; EFFECTOR CELL; EPIDERMIS; EPIDERMIS CELL; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; IMMUNOPATHOLOGY; INHIBITION KINETICS; MEMORY CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PSORIASIS; T LYMPHOCYTE; XENOTRANSPLANTATION; ANIMAL; CYTOLOGY; DRUG ANTAGONISM; GENE DELETION; GENE EXPRESSION REGULATION; METABOLISM; XENOGRAFT;

ANIMALS; ANTIBODIES, MONOCLONAL; EPIDERMIS; GENE DELETION; GENE EXPRESSION REGULATION; HUMANS; INTEGRIN ALPHA1BETA1; MICE; PSORIASIS; T-LYMPHOCYTES; TRANSPLANTATION, HETEROLOGOUS;

EID: 34447124969     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm1605     Document Type: Article

References (39)

1. Griffiths, C.E. & Voorhees, J.J. Psoriasis, T cells and autoimmunity. J. R. Soc. Med. 89, 315-319 (1996).
2. Davidson, A. & Diamond, B. Autoimmune diseases. N. Engl. J. Med. 345, 340-350 (2001).
3. Kupper, T.S. & Fuhlbrigge, R.C. Immune surveillance in the skin: mechanisms and clinical consequences. Nat. Rev. Immunol. 4, 211-222 (2004).
4. Nickoloff, B.J. & Nestle, F.O. Recent insights into the immunopathogenesis of psoriasis provide new therapeutic opportunities. J. Clin. Invest. 113, 1664-1675 (2004).
5. Bowcock, A.M. & Krueger, J.G. Getting under the skin: the immunogenetics of psoriasis. Nat. Rev. Immunol. 5, 699-711 (2005).
6. Schon, M.P. & Boehncke, W.H. Psoriasis. N. Engl. J. Med. 352, 1899-1912 (2005).
7. + T cells in psoriatic lesions preferentially use T-cell receptor V beta 3 and/or V beta 13.1 genes. Proc. Natl. Acad. Sci. USA 91, 9282-9286 (1994).
8. Krueger, J.G. et al. Successful ultraviolet B treatment of psoriasis is accompanied by a reversal of keratinocyte pathology and by selective depletion of intraepidermal T cells. J. Exp. Med. 182, 2057-2068 (1995).
9. Chamian, F. et al. Alefacept reduces infiltrating T cells, activated dendritic cells, and inflammatory genes in psoriasis vulgaris. Proc. Natl. Acad. Sci. USA 102, 2075-2080 (2005).
10. Baker, B.S., Swain, A.F., Fry, L. & Valdimarsson, H. Epidermal T lymphocytes and HLA-DR expression in psoriasis. Br. J. Dermatol. 110, 555-564 (1984).
11. Austin, L.M., Ozawa, M., Kikuchi, T., Walters, I.B. & Krueger, J.G. The majority of epidermal T cells in Psoriasis vulgaris lesions can produce type 1 cytokines, interferongamma, interleukin-2, and tumor necrosis factor-alpha, defining TC1 (cytotoxic T lymphocyte) and TH1 effector populations: a type 1 differentiation bias is also measured in circulating blood T cells in psoriatic patients. J. Invest. Dermatol. 113, 752-759 (1999).
12. Boyman, O. et al. Spontaneous development of psoriasis in a new animal model shows an essential role for resident T cells and tumor necrosis factor-α. J. Exp. Med. 199, 731-736 (2004).
13. Boyman, O., Conrad, C., Tonel, G., Gilliet, M. & Nestle, F.O. The pathogenic role of tissue-resident immune cells in psoriasis. Trends Immunol. 28, 51-57 (2007).
14. Ghohestani, R.F., Li, K., Rousselle, P. & Uitto, J. Molecular organization of the cutaneous basement membrane zone. Clin. Dermatol. 19, 551-562 (2001).
15. Bosman, F.T. & Stamenkovic, I. Functional structure and composition of the extracellular matrix. J. Pathol. 200, 423-428 (2003).
16. Hemler, M.E. VLA proteins in the integrin family: structures, functions, and their role on leukocytes. Annu. Rev. Immunol. 8, 365-400 (1990).
17. Hynes, R.O. Integrins: bidirectional, allosteric signaling machines. Cell 110, 673-687 (2002).
18. deFougerolles, A.R. Integrins in immune and inflammatory disease. In I Domains in Integrins (ed. Gullberg, D.) 165-184 (Landes Biosciences, Austin, Texas, USA, 2003).
19. Ben-Horin, S. & Bank, I. The role of very late antigen-1 in immune-mediated inflammation. Clin. Immunol. 113, 119-129 (2004).
20. Ray, S.J. et al. The collagen binding α1β1 integrin VLA-1 regulates CD8 T cell-mediated immune protection against heterologous influenza infection. Immunity 20, 167-179 (2004).
21. Fiorucci, S. et al. Importance of innate immunity and collagen binding integrin α1β1 in TNBS-induced colitis. Immunity 17, 769-780 (2002).
22. Chaudhari, U. et al. Efficacy and safety of infliximab monotherapy for plaque-type psoriasis: a randomised trial. Lancet 357, 1842-1847 (2001).
23. Reich, K. et al. Infliximab induction and maintenance therapy for moderate-to-severe psoriasis: a phase III, multicentre, double-blind trial. Lancet 366, 1367-1374 (2005).
24. Boehncke, W.H., Kellner, I., Konter, U. & Sterry, W. Differential expression of adhesion molecules on infiltrating cells in inflammatory dermatoses. J. Am. Acad. Dermatol. 26, 907-913 (1992).
25. E(CD103) β7 for tissue-specific epidermal localization of CD8+ T lymphocytes. J. Invest. Dermatol. 117, 569-575 (2001).
26. + T cells in the psoriatic epidermis: regulation by interleukins 4 and 12 and transforming growth factor-β. Br. J. Dermatol. 147, 1118-1126 (2002).
27. Sallusto, F., Geginat, J. & Lanzavecchia, A. Central memory and effector memory T cell subsets: function, generation, and maintenance. Annu. Rev. Immunol. 22, 745-763 (2004).
28. Selin, L.K. & Cornberg, M. Embedding T cells in the matrix. Nat. Med. 10, 343-345 (2004).
29. + memory T cells. J. Clin. Invest. 112, 1444-1454 (2003).
30. Christophers, E., Parzefall, R. & Braun-Falco, O. Initial events in psoriasis: quantitative assessment. Br. J. Dermatol. 89, 327-334 (1973).
31. Ragaz, A. & Ackerman, A.B. Evolution, maturation, and regression of lesions of psoriasis. New observations and correlation of clinical and histologic findings. Am. J. Dermatopathol. 1, 199-214 (1979).
32. Gotwals, P.J. et al. Divalent cations stabilize the α1β1 integrin I domain. Biochemistry 38, 8280-8288 (1999).
33. Krueger, J.G. & Bowcock, A. Psoriasis pathophysiology: current concepts of pathogenesis. Ann. Rheum. Dis. 64 (suppl. 2), ii30-ii36 (2005).
34. Nestle, F.O. et al. Plasmacytoid pre-dendritic cells (PDC) initiate psoriasis through IFN-alpha production. J. Exp. Med. 202, 135-143 (2005).
35. Nestle, F.O. & Gilliet, M. Defining upstream elements of psoriasis pathogenesis: an emerging role for interferon alpha. J. Invest. Dermatol. 125, xiv-xv (2005).
36. Boyman, O. et al. Activation of dendritic antigen-presenting cells expressing common heat shock protein receptor CD91 during induction of psoriasis. Br. J. Dermatol. 152, 1211-1218 (2005).
37. Hayday, A., Theodoridis, E., Ramsburg, E. & Shires, J. Intraepithelial lymphocytes: exploring the Third Way in immunology. Nat. Immunol. 2, 997-1003 (2001).
38. Fraki, J.E., Briggaman, R.A. & Lazarus, G.S. Transplantation of psoriatic skin onto nude mice. J. Invest. Dermatol. 80 (suppl.), 31s-35s (1983).
39. + T cells are resident in normal skin. J. Immunol. 176, 4431-4439 (2006).